CSB 2.012 Note2. N-phenyl-N-(piperidin-4-yl)propionamide, commonly known as norfentanyl.
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register June 2020 No. 774, eff. 6-29-20; CR 20-078: cr. Register July 2021 No. 787, eff. 8-1-21. CSB 2.012 NoteCSB 2.77 Scheduling of flualprazolam. Section 961.20 (2) (ef), Stats., is created to read: CSB 2.012 Note961.20 (2) (ef) Flualprazolam;
CSB 2.012 HistoryHistory: EmR1037: emerg. cr., eff. 10-27-20; CR 20-078: cr. Register July 2021 No. 787, eff. 8-1-21; correction made under s. 35.17, Stats., Register July 2021 No. 787. CSB 2.012 NoteCSB 2.78 Addition of crotonyl fentanyl to schedule I. Section 961.14 (2) (nd) 9m., Stats., is created to read: CSB 2.012 Note961.14 (2) (nd) 9m. Crotonyl Fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2- enamide);
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register November 2020 No. 779, eff. 11-23-20; CR 22-011: cr. Register June 2023 No. 810, eff. 7-1-23; correction made under s. 35.17, Stats., Register June 2023 No. 810. CSB 2.012 NoteCSB 2.79 Addition of remimazolam to schedule IV. Section 961.20 (2) (mo), Stats., is created to read: CSB 2.012 Note961.20 (2) (mo) Remimazolam;
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register November 2020 No. 779, eff. 11-23-20; CR 22-014: cr. Register June 2023 No. 810, eff. 7-1-23; correction made under s. 35.17, Stats., Register June 2023 No. 810. CSB 2.012 NoteCSB 2.80 Scheduling of oliceridine. Section 961.16 (3) (ta), Stats., is created to read: CSB 2.012 Note961.16 (3) (ta) Oliceridine;
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register December 2020 No. 780, eff. 12-14-20; CR 21-098: cr. Register August 2022 No. 800, eff. 9-1-22. CSB 2.012 NoteCSB 2.81 Addition of brorphine to schedule I. Section 961.14 (2) (et), Stats., is created to read: CSB 2.012 Note961.14 (2) (et) Brorphine;
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register May 2021 No. 785, eff. 4-26-21; correction made under s. 35.17, Stats., Register May 2021 No. 785; CR 22-016: cr. Register June 2023 No. 810, eff. 7-1-23; correction made under s. 35.17, Stats., Register June 2023 No. 810. CSB 2.012 NoteCSB 2.82 Addition of Serdexmethylphenidate to schedule IV. Section 961.20 (2m) (em), Stats., is created to read: CSB 2.012 Note961.20 (2m) (em) Serdexmethylphenidate.
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-12-21; CR 22-032: cr. Register June 2023 No. 810, eff. 7-1-23. CSB 2.012 NoteCSB 2.83 Addition of ten (10) fentanyl-related substances to schedule I. Section 961.14 (2) (nd) 21., 22., 23., 24., 25., 26., 27., 28., 29., and 30., Stats., is created to read: CSB 2.012 Note961.14 (2) (nd) 21. N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2’-fluoro ortho-fluorofentanyl; 2’-fluoro 2-fluorofentanyl);
CSB 2.012 Note22. N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide (4’-methyl acetyl fentanyl);
CSB 2.012 Note23. N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide (β’-phenyl fentanyl; beta’-Phenyl fentanyl; 3-phenylpropanoyl fentanyl);
CSB 2.012 Note24. N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide (β-methyl fentanyl);
CSB 2.012 Note25. N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl);
CSB 2.012 Note26. N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl);
CSB 2.012 Note27. 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl);
CSB 2.012 Note28. N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4-methylfentanyl);